Everspin Technologies Inc. (MRAM) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. Everspin Technologies, Inc. is a pioneer in Magnetoresistive Random Access Memory (MRAM) technology, providing non-volatile memory solutions for industrial, medical, automotive, aerospace, and data center markets. The company operates as a single reportable segment, selling products through distributors and direct channels, alongside licensing and engineering services.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Total Revenue | $13.2 million | $10.6 million | $26.3 million | $25.1 million |
| Gross Profit | $6.8 million | $5.2 million | $13.5 million | $13.4 million |
| Gross Margin | 51.3% | 49.0% | 51.3% | 53.4% |
| Net Loss | $(0.7) million | $(2.5) million | $(1.8) million | $(2.7) million |
| Adjusted Net Income | $0.7 million | $(0.6) million | $1.2 million | $0.9 million |
| Cash and Equivalents | $45.0 million (as of June 30, 2025) | |||
| Operating Cash Flow (YTD) | $6.5 million | $0.4 million |
Material Changes vs. Prior Period
- Revenue Growth: Q2 2025 revenue increased 24.1% year-over-year, driven by a 12.2% increase in product sales and a 181.7% surge in licensing, royalty, and other revenue. The latter was primarily due to progress on RAD-Hard product development and a new AI technology application agreement.
- Profitability Improvement: The net loss narrowed significantly from $2.5 million in Q2 2024 to $0.7 million in Q2 2025. Adjusted Net Income turned positive at $0.7 million for the quarter, compared to a loss of $0.6 million in the prior year.
- Operating Cash Flow: Operating cash flow improved dramatically to $6.5 million for the six months ended June 30, 2025, compared to $0.4 million in the prior year. This was largely due to a $4.4 million decrease in accounts receivable resulting from a one-time distributor transition with improved payment terms.
- Investing Activity: Capital expenditures increased to $3.9 million (YTD 2025) from $1.2 million (YTD 2024), reflecting $2.9 million in purchases of manufacturing equipment and $1.0 million in intangible assets.
Outlook, Commentary, and Risks
- Strategic Award: The company recognized $0.9 million in other income in Q2 2025 related to a strategic award to develop a long-term manufacturing plan for aerospace and defense segments. Total potential milestones for this award are approximately $14.6 million over 2.5 years.
- Liquidity: Management believes current cash reserves of $45.0 million are sufficient to meet capital requirements for the next 12 months.
- Tax Legislation: The company is assessing the impact of the "One Big Beautiful Bill Act" (OBBBA), enacted July 4, 2025, which includes permanent extensions of certain tax provisions and modifications to the international tax framework.
- Risks: The filing references standard risk factors including dependence on key customers (Customer C represented 61% of receivables at year-end 2024, though Q2 2025 concentration was lower), supply chain dependencies, and the need for continued R&D investment.
Investor Verification Checklist
- Revenue Quality: Verify the sustainability of the 181.7% increase in licensing and other revenue, which is described as highly variable and transaction-based.
- Customer Concentration: Review the specific revenue and receivable concentration for "Customer A" (14% revenue in Q2 2025) and "Customer D" (20% revenue in Q2 2025) to assess dependency risks.
- Capital Expenditure Plan: Confirm the timeline and expected ROI for the $2.9 million in manufacturing equipment purchases made in the first half of 2025.
- Adjusted Net Income: Note that Adjusted Net Income excludes stock-based compensation ($3.0 million YTD); investors should weigh this non-GAAP metric against the GAAP net loss.
- Inventory Levels: Inventory increased by $2.2 million YTD 2025; verify if this aligns with expected production ramp-ups or potential demand softness.